from PR Newswire
Depomed Reports First Quarter 2013 Financial Results
May 08, 2013
from PR Newswire
Depomed To Report First Quarter Fiscal Year 2013 Financial Results On Wednesday, May 8, 2013
May 01, 2013
from PR Newswire
from PR Newswire
Depomed Provides Update on SEFELSA™ FDA Advisory Committee
March 04, 2013
from PR Newswire
Trading of Depomed Common Stock Halted
March 04, 2013
Advisory Committee of the Food and Drug Administration to Discuss SEFELSA™ New Drug Application for the Treatment of Moderate to Severe Vasomotor Symptoms Read More
from PR Newswire
Depomed To Present At Cowen and Company Health Care Conference
February 26, 2013
from PR Newswire
Depomed Reports Fourth Quarter and Full Year 2012 Financial Results
February 20, 2013
from PR Newswire
Depomed To Report Fourth Quarter Fiscal Year 2012 Financial Results On Wednesday, February 20, 2013
February 13, 2013
from PR Newswire
Depomed Announces Appointment of Vicente J. Anido, Jr., Ph.D. to Board of Directors, and Retirement of Directors Julian N. Stern and Craig R. Smith, M.D.
February 11, 2013
from PR Newswire
EmergingGrowth.com Special Report on RVPlus, Inc., Oil and Gas, and Patents infringement in Pharmaceuticals
December 28, 2012
from PR Newswire
Depomed Announces Dismissal Of Suit Against Two Gralise ANDA Filers Following Withdrawal Of ANDA And Patent Challenge
December 26, 2012
from PR Newswire
Depomed To Present At Oppenheimer 2012 Healthcare Conference
December 03, 2012
from PR Newswire
Depomed To Present At Piper Jaffray 2012 Healthcare Conference
November 19, 2012
from PR Newswire
Depomed Reports Top Line Data for Phase 2 Study in Parkinson's Disease
November 07, 2012
from PR Newswire
Depomed To Present At Lazard 2012 Healthcare Conference
November 06, 2012
from PR Newswire
Depomed Reports Third Quarter Financial Results
November 05, 2012
from PR Newswire
Depomed To Report Third Quarter Fiscal Year 2012 Financial Results On Monday, November 5, 2012
October 29, 2012
from PR Newswire
from PR Newswire
Depomed, Inc. Appoints Dr. Samuel Saks To Its Board Of Directors
October 09, 2012
from PR Newswire
BREEZE 3 data for Serada® presented at 2012 North American Menopause Society Annual Meeting
October 03, 2012
from PR Newswire
Breeze 3 data for Serada® presented at 2012 North American Menopause Society Annual Meeting
October 03, 2012
from PR Newswire
from PR Newswire
Depomed Files Suit Against The FDA Seeking Grant Of Orphan Drug Exclusivity For Gralise® (Gabapentin)
September 25, 2012
from PR Newswire
Depomed To Present At UBS Global Life Sciences Conference
September 14, 2012
from PR Newswire
Depomed To Present At Morgan Stanley 2012 Healthcare Conference
September 06, 2012
from PR Newswire
Depomed To Present At Morgan Stanley 2012 Healthcare Conference
September 06, 2012
from PR Newswire
from PR Newswire
Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
August 24, 2012
from PR Newswire
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here